The BMC is a Canadian, state-of-the-art, end-to-end GMP facility dedicated to the production of biologics—including antibodies, viral vector vaccines (protein subunits, VLPs), and other complex biopharmaceuticals.

The BMC offer a full suite of services: tech transfer, cGMP manufacturing, QC testing, fill-finish, secondary packaging, and strategic consulting.

At the BMC, our model was built to solve common CDMO pain points:

– Rapid onboarding and efficient tech transfer

– Transparent project management with clear timelines

– Flexibility for early-stage and commercial-scale production

– In-house analytical support and regulatory insight

Whether you’re developing a clinical candidate or scaling commercial supply, we offer a tailored, responsive approach.

Company (Headquarters):

Canada

Types of Drugs Manufactured:

Biologics

CDMO Services:

Drug Substance Manufacturing (API);Drug Product/FDF;Packaging(Commercial);Analytical Development;Packaging (Clinical);Process & Forumulation Development

CDMO Number of Facilities:

1

Facilities Location:

North America

Manufacturing Technologies:

Cartridges;Pre-Filled Syringes (PFS);Sterile Vials